Snowden Capital Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Snowden Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $6,034 - $8,843	76 Added 1.59%	4,865 $388,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $407,815 - $518,193	4,719 Added 6741.43%	4,789 $503,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $6,899 - $8,393	70 New	70 $7,000
Q3 2021 Feb 05, 2024	BUY	$91.91 - $110.37 $422,142 - $506,929	4,593 New	4,593 $503 Million
Q1 2020 Jan 08, 2024	SELL	$24.87 - $38.56 $1.37 Million - $2.12 Million	-55,000 Closed	0 $0
Q4 2019 Jan 08, 2024	BUY	$25.43 - $36.67 $1.4 Million - $2.02 Million	55,000 New	55,000 $19.9 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.